Nature Reviews Gastroenterology & Hepatology

Nature Reviews Gastroenterology & Hepatology, published by Springer Nature under the ISSN 1759-5045, is a premier monthly peer-reviewed journal that occupies the highest tier in its field, as reflected by its 2026 Impact Factor of 57.500 and its consistent placement in JCR Quartile Q1. The journal’s scope encompasses the full spectrum of clinical and translational science within gastroenterology and hepatology, covering conditions such as inflammatory bowel disease, functional gastrointestinal disorders, liver cirrhosis, viral hepatitis, pancreatic diseases, and gastrointestinal malignancies. It prioritizes authoritative, synthesized content over primary research, publishing predominantly invited Review articles, Perspectives, and Consensus Statements that critically evaluate recent advances, emerging concepts, and clinical best practices. The journal also features News & Views pieces, Research Highlights that distill key findings from the broader literature, and occasional Correspondence. Its target audience includes academic clinicians, clinical researchers, gastroenterologists, hepatologists, and allied health professionals seeking high-level, evidence-based syntheses to inform clinical decision-making and future research directions. Notable features include a hybrid open-access model, allowing authors to publish their articles open access or via the traditional subscription route, and the journal’s affiliation with the Nature Reviews family, which ensures rigorous editorial oversight, expert peer review, and high-quality visual presentation. As a top-quartile journal with an impact factor among the highest in the specialty, Nature Reviews Gastroenterology & Hepatology is widely regarded as an essential reference for staying current with transformative developments in digestive health and liver disease.